During the MedCity INVEST Digital Health conference in Dallas, three executives shared what’s top of mind as they deploy AI in the healthcare workforce, including the need to build trust and improve ...

During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.

From left to right: Soumi Saha, senior vice president of government affairs at Premier Inc.; Jennifer Goldsack, founder and CEO of the Digital Medicine Society Hallucinations are a frequent point of ...

Virtual specialty care platform AmplifyMD, which aims to help hospitals do more with fewer doctors, scored $20 million dollars this Wednesday in a Series B financing round led by Forerunner Ventures.

A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...

Duke University Health System is deploying a mix of homegrown and purchased AI tools to ease clinicians’ administrative burden and improve patient care. Chief Nurse Executive Terry McDonnell ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...

Coronary disease is one of the most significant causes of death among women in the United States; it is responsible for one in every three deaths. Advancing age, along with other contributing factors, ...

AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention — are gaining traction in the healthcare world. The industry is under massive pressure ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...